Tenders of Dak Gesundheit

Tenders of Dak Gesundheit

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Closing Date5 Jun 2026
Tender AmountEUR 1 (USD 1)
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Absatz 8 Sgb V Zum Wirkstoff Omalizumab, Atc R03dx05 (obo) Für Die Zeit 01.08.2024 - 31.07.2025 (zzgl. Verlängerungsoption 1x12 Monate)

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Closing Date5 Jun 2026
Tender AmountRefer Documents 
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient pomalidomide, ATC L04ax06 (obg) for the period 01.08.2024 - 31.07.2026

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Closing Date5 Jun 2026
Tender AmountEUR 1 (USD 1)
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Absatz 8 Sgb V Zum Wirkstoff Bimatoprost + Timolol (ausschließlich Edo), Atc S01ed62 (obo) Für Die Zeit 01.08.2024 - 31.07.2026

DAK Gesundheit Tender

Healthcare and Medicine...+1Chemical Products
Germany
Closing Date5 Jun 2026
Tender AmountRefer Documents 
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient colistin, ATC J01xb01 (obg) for the period 01.08.2024 - 31.07.2026

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Closing Date5 May 2026
Tender AmountRefer Documents 
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient etravirine, ATC J05ag04 (obo) for the period 01.07.2024 - 30.06.2026

DAK Gesundheit Tender

Healthcare and Medicine...+1Chemical Products
Germany
Closing Date5 May 2026
Tender AmountRefer Documents 
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient ixekizumab, ATC L04ac13 (obo) for the period 01.07.2024 - 30.06.2026

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Closing Date5 May 2026
Tender AmountRefer Documents 
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient piribedil, ATC N04BC08 (obo) for the period 01.07.2024 - 30.06.2025 (one-year extension option)

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Closing Date5 May 2026
Tender AmountRefer Documents 
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient propranolol (exclusively Lse), ATC C07aa05 (obo) for the period 01.07.2024 - 30.06.2026

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Closing Date5 May 2026
Tender AmountEUR 1 (USD 1)
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Absatz 8 Sgb V Zum Wirkstoff Ixekizumab, Atc L04ac13 (obo) Für Die Zeit 01.07.2024 - 30.06.2026

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Closing Date5 May 2026
Tender AmountEUR 1 (USD 1)
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Absatz 8 Sgb V Zum Wirkstoff Etravirin, Atc J05ag04 (obo) Für Die Zeit 01.07.2024 - 30.06.2026
151-160 of 331 active Tenders